• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚昆士兰州慢性肾病监测和研究

CKD.QLD: chronic kidney disease surveillance and research in Queensland, Australia.

机构信息

Renal Medicine, Toowoomba Hospital, Toowoomba, Queensland, Australia.

出版信息

Nephrol Dial Transplant. 2012 Oct;27 Suppl 3(Suppl 3):iii139-45. doi: 10.1093/ndt/gfs258.

DOI:10.1093/ndt/gfs258
PMID:23115138
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3484715/
Abstract

BACKGROUND

Chronic kidney disease (CKD) is recognized as a major public health problem in Australia with significant mortality, morbidity and economic burden. However, there is no comprehensive surveillance programme to collect, collate and analyse data on CKD in a systematic way.

METHODS

We describe an initiative called CKD Queensland (CKD.QLD), which was established in 2009 to address this deficiency, and outline the processes and progress made to date. The foundation is a CKD Registry of all CKD patients attending public health renal services in Queensland, and patient recruitment and data capture have started.

RESULTS

We have established through early work of CKD.QLD that there are over 11,500 CKD patients attending public renal services in Queensland, and these are the target population for our registry. Progress so far includes conducting two CKD clinic site surveys, consenting over 3000 patients into the registry and initiation of baseline data analysis of the first 600 patients enrolled at the Royal Brisbane and Women's Hospital (RBWH) site. In addition, research studies in dietary intake and CKD outcomes and in models of care in CKD patient management are underway.

CONCLUSIONS

Through the CKD Registry, we will define the distribution of CKD patients referred to renal practices in the public system in Queensland by region, remoteness, age, gender, ethnicity and socioeconomic status. We will define the clinical characteristics of those patients, and the CKD associations, stages, co-morbidities and current management. We will follow the course and outcomes in individuals over time, as well as group trends over time. Through our activities and outcomes, we are aiming to provide a nidus for other states in Australia to join in a national CKD registry and network.

摘要

背景

慢性肾脏病(CKD)在澳大利亚被认为是一个主要的公共卫生问题,其具有较高的死亡率、发病率和经济负担。然而,目前还没有一个全面的监测计划来系统地收集、整理和分析 CKD 数据。

方法

我们描述了一项名为昆士兰 CKD(CKD.QLD)的计划,该计划于 2009 年成立,旨在解决这一不足,并概述了迄今为止取得的进展和过程。该计划的基础是一个涵盖所有在昆士兰州公共卫生肾脏服务就诊的 CKD 患者的 CKD 登记处,目前已经开始招募患者和数据采集工作。

结果

通过 CKD.QLD 的早期工作,我们发现昆士兰州有超过 11500 名 CKD 患者在接受公共肾脏服务,这些患者是我们登记处的目标人群。迄今为止的进展包括进行了两次 CKD 诊所现场调查,同意将 3000 多名患者纳入登记处,并开始对在皇家布里斯班妇女医院(RBWH)登记的前 600 名患者进行基线数据分析。此外,正在进行关于 CKD 患者管理中饮食摄入和 CKD 结局以及护理模式的研究。

结论

通过 CKD 登记处,我们将根据地区、偏远程度、年龄、性别、种族和社会经济地位来确定在昆士兰州公共系统中被转诊到肾脏实践的 CKD 患者的分布情况。我们将确定这些患者的临床特征,以及 CKD 关联、分期、合并症和当前管理情况。我们将随着时间的推移跟踪个体的病程和结局,以及随时间推移的群体趋势。通过我们的活动和成果,我们旨在为澳大利亚其他州加入国家 CKD 登记处和网络提供一个核心。

相似文献

1
CKD.QLD: chronic kidney disease surveillance and research in Queensland, Australia.澳大利亚昆士兰州慢性肾病监测和研究
Nephrol Dial Transplant. 2012 Oct;27 Suppl 3(Suppl 3):iii139-45. doi: 10.1093/ndt/gfs258.
2
Chronic kidney disease, Queensland: Profile of patients with chronic kidney disease from regional Queensland, Australia: A registry report.慢性肾脏病,昆士兰州:来自澳大利亚昆士兰州地区的慢性肾脏病患者概况:注册报告。
Nephrology (Carlton). 2019 Dec;24(12):1257-1264. doi: 10.1111/nep.13567. Epub 2019 May 2.
3
CKD.QLD: establishment of a chronic kidney disease [CKD] registry in Queensland, Australia.慢性肾脏病。昆士兰:在澳大利亚昆士兰建立慢性肾脏病(CKD)登记处。
BMC Nephrol. 2017 Jun 7;18(1):189. doi: 10.1186/s12882-017-0607-5.
4
Spectrum (characteristics) of patients with chronic kidney disease (CKD) with increasing age in a major metropolitan renal service.在一家大型都市肾脏服务机构中,慢性肾脏病(CKD)患者随年龄增长的谱(特征)。
BMC Nephrol. 2017 Dec 28;18(1):372. doi: 10.1186/s12882-017-0781-5.
5
Referral patterns, disease progression and impact of the kidney failure risk equation (KFRE) in a Queensland Chronic Kidney Disease Registry (CKD.QLD) cohort: a study protocol.昆士兰慢性肾脏病登记处(CKD.QLD)队列中转诊模式、疾病进展及肾衰竭风险方程(KFRE)的影响:研究方案。
BMJ Open. 2022 Feb 22;12(2):e052790. doi: 10.1136/bmjopen-2021-052790.
6
Body mass index in an Australian population with chronic kidney disease.澳大利亚慢性肾病患者群体的体重指数
BMC Nephrol. 2018 Aug 20;19(1):209. doi: 10.1186/s12882-018-1006-2.
7
Protocol and establishment of a Queensland renal biopsy registry in Australia.澳大利亚昆士兰肾脏活检登记处的建立与规程。
BMC Nephrol. 2020 Aug 1;21(1):320. doi: 10.1186/s12882-020-01983-7.
8
Hyperuricaemia, gout and allopurinol in the CKD Queensland registry.CKD 昆士兰注册研究中的高尿酸血症、痛风和别嘌醇。
J Nephrol. 2021 Jun;34(3):753-762. doi: 10.1007/s40620-020-00937-4. Epub 2021 Jan 13.
9
Blood pressure management in hypertensive people with non-dialysis chronic kidney disease in Queensland, Australia.澳大利亚昆士兰州非透析慢性肾病高血压患者的血压管理。
BMC Nephrol. 2019 Sep 4;20(1):348. doi: 10.1186/s12882-019-1532-6.
10
Impact of cardiovascular events on mortality and progression of renal dysfunction in a Queensland CKD cohort.昆士兰慢性肾脏病队列中心血管事件对死亡率和肾功能障碍进展的影响。
Nephrology (Carlton). 2020 Nov;25(11):839-844. doi: 10.1111/nep.13745. Epub 2020 Jul 1.

引用本文的文献

1
The Diagnostic Performance of a Clinical Diagnosis of Diabetic Kidney Disease.糖尿病肾病临床诊断的诊断效能
Life (Basel). 2023 Jun 30;13(7):1492. doi: 10.3390/life13071492.
2
The Impact of Anaemia on Outcomes, Admissions, and Costs in Patients with Chronic Kidney Disease in Two Public Nephrology Practices in Queensland: A CKD.QLD Registry Study.昆士兰两家公立肾脏病诊所中贫血对慢性肾脏病患者的预后、住院情况及费用的影响:一项CKD.QLD注册研究
Int J Nephrol. 2023 May 3;2023:8720293. doi: 10.1155/2023/8720293. eCollection 2023.
3
Identification of factors associated with high-cost use of inpatient care in chronic kidney disease: a registry study.

本文引用的文献

1
Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis.血液透析患者新型预后生物标志物的临床实用性。
Nat Rev Nephrol. 2011 Nov 1;8(3):141-50. doi: 10.1038/nrneph.2011.170.
2
Biomarkers in chronic kidney disease: a review.慢性肾脏病的生物标志物:综述。
Kidney Int. 2011 Oct;80(8):806-21. doi: 10.1038/ki.2011.198. Epub 2011 Jun 22.
3
Cohort profile: the 45 and up study.队列简介:45岁及以上研究。
识别与慢性肾脏病住院患者高费用使用相关的因素:一项注册研究。
BMJ Open. 2021 Aug 19;11(8):e049755. doi: 10.1136/bmjopen-2021-049755.
4
CKDNET, a quality improvement project for prevention and reduction of chronic kidney disease in the Northeast Thailand.CKDNET,一个在泰国东北部预防和减少慢性肾脏病的质量改进项目。
BMC Public Health. 2020 Aug 27;20(1):1299. doi: 10.1186/s12889-020-09387-w.
5
Frequency and Consequences of Acute Kidney Injury in Patients With CKD: A Registry Study in Queensland Australia.慢性肾脏病患者急性肾损伤的发生率及后果:澳大利亚昆士兰州的一项登记研究
Kidney Med. 2019 Jul 13;1(4):180-190. doi: 10.1016/j.xkme.2019.06.005. eCollection 2019 Jul-Aug.
6
Blood pressure management in hypertensive people with non-dialysis chronic kidney disease in Queensland, Australia.澳大利亚昆士兰州非透析慢性肾病高血压患者的血压管理。
BMC Nephrol. 2019 Sep 4;20(1):348. doi: 10.1186/s12882-019-1532-6.
7
Chronic Kidney Disease, Queensland (CKD.QLD) Registry: Management of CKD With Telenephrology.昆士兰慢性肾脏病(CKD.QLD)登记处:远程肾脏病学对慢性肾脏病的管理
Kidney Int Rep. 2018 Jul 21;3(6):1336-1343. doi: 10.1016/j.ekir.2018.07.013. eCollection 2018 Nov.
8
Body mass index in an Australian population with chronic kidney disease.澳大利亚慢性肾病患者群体的体重指数
BMC Nephrol. 2018 Aug 20;19(1):209. doi: 10.1186/s12882-018-1006-2.
9
Validated registry of pre-dialysis chronic kidney disease: description of a large cohort.经验证的透析前慢性肾脏病登记系统:一个大型队列的描述
J Bras Nefrol. 2018 Apr-Jun;40(2):112-121. doi: 10.1590/2175-8239-JBN-3841. Epub 2018 Jun 7.
10
CKD Screening and Surveillance in Australia: Past, Present, and Future.澳大利亚的慢性肾脏病筛查与监测:过去、现在与未来
Kidney Int Rep. 2017 Oct 6;3(1):36-46. doi: 10.1016/j.ekir.2017.09.012. eCollection 2018 Jan.
Int J Epidemiol. 2008 Oct;37(5):941-7. doi: 10.1093/ije/dym184. Epub 2007 Sep 19.
4
Prevalence of albuminuria in Australia: the AusDiab Kidney Study.澳大利亚白蛋白尿患病率:澳大利亚糖尿病肾脏研究
Kidney Int Suppl. 2004 Nov(92):S22-4. doi: 10.1111/j.1523-1755.2004.09206.x.
5
Prevalence of kidney damage in Australian adults: The AusDiab kidney study.澳大利亚成年人肾脏损伤患病率:澳大利亚糖尿病肾脏研究
J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S131-8. doi: 10.1097/01.asn.0000070152.11927.4a.